JERSEY SHORE UNIVERSITY MED CTR
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $8.1M
- Transactions
- 858
- Companies
- 40
- Average per transaction
- $9,474
Who reported the payments
| Amgen | $2,094,290 |
| Janssen Research & Development, LLC | $1,290,241 |
| E.r. Squibb & Sons, L.L.C. | $1,195,602 |
| Karyopharm Therapeutics Inc. | $829,224 |
| Gilead | $552,421 |
| Regeneron | $484,940 |
| Tesaro, Inc. | $194,847 |
| Pharmacyclics LLC, An Abbvie Company | $171,528 |
| Intuitive Surgical | $164,315 |
| Takeda Pharmaceuticals U.S.A., Inc. | $152,909 |
| Mallinckrodt Hospital Products Inc. | $141,592 |
| Silk Road Medical, Inc. | $77,749 |
| Abiomed | $77,125 |
| Merck | $74,804 |
| Bard Peripheral Vascular, Inc. | $52,575 |
| GT Medical Technologies, Inc | $52,372 |
| Roche Products Limited | $43,228 |
| Ventana Medical Systems, Inc. | $39,078 |
| Genentech, Inc. | $38,664 |
| Zimvie Inc. | $34,982 |
| Olympus America Inc. | $31,620 |
| Acadia Pharmaceuticals Inc | $28,700 |
| Impulse Dynamics (USA) Inc. | $25,975 |
| Sekisui Diagnostics LLC | $24,625 |
| Mallinckrodt Enterprises LLC | $20,940 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $20,750 |
| Shockwave Medical, Inc | $20,395 |
| Insmed, Inc. | $19,850 |
| AbbVie | $19,220 |
| Novartis | $16,982 |
| Mirati Therapeutics, Inc. | $14,342 |
| Medartis Inc. | $13,240 |
| W. L. Gore & Associates, Inc. | $12,000 |
| Linvatec Corporation | $11,902 |
| Stryker | $9,728 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $8,050 |
| Zimmer Biomet | $6,824 |
| Inari Medical, Inc. | $6,700 |
| Macrogenics, Inc. | $5,993 |
| CSL Behring | $3,923 |